Close Menu
Beverly Hills Examiner

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Startup sues Apple in India over tap-to-share contacts feature | TechCrunch

    November 21, 2026

    The US to become first nation to fully shun a UN Human Rights Council review

    November 21, 2026

    Grimes Releases Two New Psy Opera Songs

    November 20, 2026
    Facebook X (Twitter) Instagram
    Beverly Hills Examiner
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    Beverly Hills Examiner
    Home»Science»Blood Tests for Alzheimer’s Are Here
    Science

    Blood Tests for Alzheimer’s Are Here

    By AdminNovember 7, 2025
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Blood Tests for Alzheimer’s Are Here

    [ad_1]

    Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a specific molecule—a phosphorylated form of the tau protein—in the blood. Tau is one of two proteins, the other being amyloid, that become malformed and accumulate in the brains of patients with certain types of dementia. It is believed that the buildup of these proteins interferes with the communication of brain cells, leading to these patients’ symptoms.

    The test had already received authorization in July for marketing in Europe and is thus the first early screening system for Alzheimer’s for use in primary care settings approved in the planet’s two major pharmaceutical markets. It is an opener in what should soon become a crowded field, as there are several other tests in advanced stages of testing and approval.

    How Do Such Tests Work?

    Elecsys pTau181 looks in the blood plasma for a form of the tau protein that has a phosphate group attached, which is often found in elevated amounts in Alzheimer’s patients. This molecule is an indirect marker of the plaques of amyloid and neurofibrillary tangles of tau observed in the brains of patients with the disease.

    Some other tests have also been approved, though not for early screening. These assess other biomarkers that relate to these two proteins. One test, called Lumipulse and made by the Japanese company Fujirebio, looks at the ratio between another form of phosphorylated tau (pTau217) and a key protein fragment that forms amyloid plaques (amyloid beta peptide 1-42).

    The bottom line is that these tests offer clues to the probable presence of amyloidosis in the brain, which then needs to be diagnosed with greater accuracy using more invasive tests, such as a PET (positron emission tomography) scan and cerebrospinal fluid analysis by lumbar puncture, considered the clinical gold standard for diagnosing amyloid pathology in living patients. Even these, however, come with some degree of uncertainty; true diagnostic certainty can only be had with a post-mortem dissection of the brain.

    Why Approve These Tests Now?

    In the past, confirmation of an Alzheimer’s diagnosis was not that important, as there were no drugs or therapies that could alter the course of the disease. But with the approval of new Alzheimer’s monoclonal antibody treatments, the landscape has changed in the past few years.

    To use these medicines, you need a way to confirm which patients can benefit. And since the drugs ideally yield the best results when used early on in the disease’s progression, a relatively inexpensive and minimally invasive diagnostic test will be extremely useful. Subjecting all elderly people with suspected symptoms of cognitive decline to PET scans and cerebrospinal fluid sampling is impractical, so this is where blood testing for Alzheimer’s comes in.

    Just How Useful Are These Tests?

    Elecsys pTau181 is the first test to be approved for use as a community-screening tool. The idea is for it to be administered at the primary care level—so, for instance, by a primary care physician or general practitioner. The test has been shown to have a good “negative predictive value”—that is, it is effective at accurately indicating who does not have amyloid disease. In settings where the overall prevalence of amyloid disease is low, a negative result from this test is 97.9 percent reliable. This makes it useful for selecting which patients to put forward for further testing.

    The results are similar to those of other tests that have already been approved in recent months, such as Lumipulse from Japan’s Fujirebio, which in trials has shown a negative predictive value of about 97 percent.

    However, there is an important limitation to note: for all blood tests for Alzheimer’s, there tends to be a relatively large proportion of patients (15-30 percent is a common estimate) who fall into a gray area of uncertainty, in which the levels of identified biomarkers do not allow for either a positive or a negative answer.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleYorgos Lanthimos, Bugonia, and the Long Shadow of…
    Next Article Tesla delays reveal of production Roadster 2 to April Fools’ Day

    RELATED POSTS

    Voyager 1 Beat the Odds and Is Still Working a Light-Day Away From Earth

    November 18, 2026

    The Dark Side of the Moon Was the Brightest Part of 2026

    November 17, 2026

    Just 400 US Data Centers Use More Electricity Than Michigan

    November 16, 2026

    The EPAs Chemical-Detecting Plane Isnt Doing Its Job Anymore

    November 16, 2026

    Its Getting Too Dry for Even Cactuses to Survive

    November 15, 2026

    New Species of Giant Fungus Discovered in China Grows up to 20 Inches Tall

    November 15, 2026
    latest posts

    Startup sues Apple in India over tap-to-share contacts feature | TechCrunch

    Apple is being sued in India by a U.S.-based startup that alleges the iPhone maker’s…

    The US to become first nation to fully shun a UN Human Rights Council review

    November 21, 2026

    Grimes Releases Two New Psy Opera Songs

    November 20, 2026

    Book Riots Deals of the Day for November 20, 2026

    November 20, 2026

    Chips can survive the space environment. Can their financing? | TechCrunch

    November 20, 2026

    AI stocks are selling off after Anthropics record IPO, and Wall Street is split on whether this is the top | Fortune

    November 20, 2026

    NYC sightseeing helicopter makes emergency landing after reporting possible engine trouble

    November 20, 2026
    Categories
    • Books (1,620)
    • Business (6,525)
    • Cover Story (17)
    • Film (6,459)
    • Lifestyle (4,500)
    • Music (6,535)
    • Politics (6,511)
    • Science (5,865)
    • Technology (6,463)
    • Television (6,156)
    • Uncategorized (3)
    • US News (6,509)
    popular posts

    New Jane’s Addiction Music on Its Way, Says Perry Farrell

    [ad_1] Finally, there’s some signs of life from Jane’s Addiction — and it could include new…

    Photoncycle targets low-cost energy storage with a clever hydrogen solution

    April 2, 2024

    Ozzy and Sharon Osbourne’s Dog Elvis Has Passed Away

    October 20, 2025

    Protests against Netanyahu, risks to economy

    March 1, 2023
    Archives
    Browse By Category
    • Books (1,620)
    • Business (6,525)
    • Cover Story (17)
    • Film (6,459)
    • Lifestyle (4,500)
    • Music (6,535)
    • Politics (6,511)
    • Science (5,865)
    • Technology (6,463)
    • Television (6,156)
    • Uncategorized (3)
    • US News (6,509)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    AI stocks are selling off after Anthropics record IPO, and Wall Street is split on whether this is the top | Fortune

    November 20, 2026

    NYC sightseeing helicopter makes emergency landing after reporting possible engine trouble

    November 20, 2026

    Billie Eilish to Headline BST Hyde Park for First Time: She Inspires Fans, Challenges Our Industry to Be Better

    November 20, 2026
    © 2026 Beverly Hills Examiner. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT